Nanozyme-Catalyzed Lateral Flow Assay for the Simultaneous Detection of RNA and Protein Biomarkers
ACS Nano · 04.11.2026
DOI: 10.1021/acsnano.6c12112 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 04.11.2026. Verfasst von Chaewon Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Anatomy and Genetics, Department of Engineering Science, Kavli Institute for Nanoscience Discovery, University of Oxford, O…. Hauptthemen laut MEDLINE: RNA, Natriuretic Peptide, Brain. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, British Heart Foundation, Royal Academy of Engineering.
Abstract (Originalsprache)
Molecular diagnostics have advanced rapidly over the past decade, driven by the demand for accessible and scalable testing solutions. However, current assays often focus on single biomolecule types, limiting their ability to capture the multifactorial nature of disease. Integrating distinct molecular readouts─such as transcriptomic and proteomic biomarkers─could provide richer diagnostic information and improve clinical decision-making. Here, we present MOSAIC (Multiplexed Orthogonal Sensing Assay Integrated with CRISPRZyme), a unified lateral flow assay that enables simultaneous detection of RNA and protein biomarkers using a shared nanozyme-catalyzed readout. The assay combines CRISPR/Cas13a-mediated RNA detection and antibody-based protein detection, with assay components optimized through antibody conjugation tuning, blocking agent optimization, and probe loading calibration to achieve balanced and cross-talk-free performance. Using cardiovascular disease as a model, the platform successfully detects NTproBNP and LIPCAR long noncoding RNA simultaneously from the same sample. The assay was further optimized for spiked human plasma, incorporating tailored pretreatment and recombinase polymerase amplification (RPA) to maintain RNA stability and performance in complex biofluids. Extending its versatility, the same assay design was adapted to detect SARS-CoV-2 biomarkers, the spike (S) protein and ORF1ab gene, in pooled human saliva. To enable standardized interpretation of multiplexed readouts, we additionally developed a machine-learning-assisted computational workflow that automates strip localization, signal extraction, and calibration curve construction. Together, these results demonstrate a modular, paper-based diagnostic platform that unites transcriptomic and proteomic analyses within one assay architecture, offering a practical step toward accessible and multiplexed molecular diagnostics across diverse disease contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Anatomy and Genetics, Department of Engineering Science, Kavli Institute for Nanoscience Discovery, University of Oxford, OxfordOX1 3QU, U.K.
- Department of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London, LondonSW7 2AZ, U.K.
- National Heart and Lung Institute, Imperial College London, LondonSW3 6LY, U.K.
- Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, LondonSW3 6NP, U.K.
ORCID-Profile: Ho-Cheung Ng, Christy J Sadler, Molly M Stevens
Förderung
- Wellcome Trust
- British Heart Foundation
- Royal Academy of Engineering
- University of Oxford
- Rosetrees Trust
- National Research Foundation of Korea
- UK Research and Innovation
- NIHR Imperial Biomedical Research Centre
Zitieren
APA
Park, C., Dissanayake-Perera, S., Ng, H. C., Sadler, C. J., Gallego Rubio, C., Nam, K., Prasad, S. K., & Stevens, M. M. (2026). Nanozyme-Catalyzed Lateral Flow Assay for the Simultaneous Detection of RNA and Protein Biomarkers. ACS Nano. https://doi.org/10.1021/acsnano.6c12112
Vancouver
Park C, Dissanayake-Perera S, Ng HC, Sadler CJ, Gallego Rubio C, Nam K, et al. Nanozyme-Catalyzed Lateral Flow Assay for the Simultaneous Detection of RNA and Protein Biomarkers. ACS Nano. 2026. doi:10.1021/acsnano.6c12112
BibTeX
@article{Park2026,
author = {Park, Chaewon and Dissanayake-Perera, Schan and Ng, Ho-Cheung and Sadler, Christy J and Gallego Rubio, Cecilia and Nam, Keonwook and Prasad, Sanjay K and Stevens, Molly M},
title = {Nanozyme-Catalyzed Lateral Flow Assay for the Simultaneous Detection of RNA and Protein Biomarkers},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c12112}
}
EUVIMED